Glucose level control system with control parameter modification

An automated glucose control system configured to autonomously modify a control parameter used by a control algorithm to generate a dose control signal that causes therapy to be provided to a subject, the automated glucose control system comprising:

• a medicament delivery interface configured to operatively connect to a medicament pump for infusing medicament into the subject;
• a memory configured to store specific computer-executable instructions and therapy data;
• and
• a hardware processor in communication with the memory and configured to execute the specific computer-executable instructions to at least:
• receive a first value of a control parameter used by a control algorithm to generate the dose control signal, wherein the first value is received via one or more of a plurality of control parameter value selection processes, wherein the plurality of control parameter value selection processes comprises:
• receiving a value in response to a user interaction with a user interface;
• receiving, via an electronic communications interface, a value specified by a system external to the glucose control system;
• receiving a value corresponding to a prescription provided by a healthcare provider of the subject;
• determining a value using physiological characteristics of the subject;
• determining a value using demographic characteristics of the subject;
• determining a value based on historical therapy data;
• and
• determining a value based on a history of prior glucose control data;
• cause first therapy to be delivered to the subject during a first therapy period, wherein the first therapy is delivered based at least in part on the first value of the control parameter;
• determine a second value of the control parameter, wherein the second value is determined as a function based on an effect corresponding at least in part to the first therapy;
• and
• cause second therapy to be delivered by the glucose control system to the subject during a second therapy period, wherein the second therapy is delivered based at least in part on the second value of the control parameter, and wherein delivering the second therapy based at least in part on the second value modifies the therapy provided to the subject compared to delivery of therapy based at least in part on the first value.